![Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AML]()
Toward personalized therapy in AML: in vivo benefit of targeting aberrant epigenetics in MLL-PTD-associated AMLBernot, K M; Siebenaler, R F; Whitman, S P; Zorko, N A; Marcucci, G G; Santhanam, R; Ahmed, E H; Ngangana, M; McConnell, K K; Nemer, J S; Brook, D L; Kulp, S K; Chen, C S; Frankhouser, D; Yan, P; Bundschuh, R; Zhang, X; Dorrance, A M; Dickerson, K E; Jarjoura, D; Blum, W; Marcucci, G; Caligiuri, M A · Leukemia · 2013